Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249033
Max Phase: Preclinical
Molecular Formula: C48H68I2N14O9
Molecular Weight: 1238.97
Molecule Type: Protein
Associated Items:
ID: ALA3249033
Max Phase: Preclinical
Molecular Formula: C48H68I2N14O9
Molecular Weight: 1238.97
Molecule Type: Protein
Associated Items:
Canonical SMILES: CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](Cc1cc(I)c(N)c(I)c1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C
Standard InChI: InChI=1S/C48H68I2N14O9/c1-25(2)39(62-41(66)32(58-37(65)23-54-5)13-9-15-56-48(52)53)44(69)59-33(20-28-17-30(49)38(51)31(50)18-28)42(67)63-40(26(3)4)45(70)60-34(21-29-22-55-24-57-29)46(71)64-16-10-14-36(64)43(68)61-35(47(72)73)19-27-11-7-6-8-12-27/h6-8,11-12,17-18,22,24-26,32-36,39-40,54H,9-10,13-16,19-21,23,51H2,1-5H3,(H,55,57)(H,58,65)(H,59,69)(H,60,70)(H,61,68)(H,62,66)(H,63,67)(H,72,73)(H4,52,53,56)/t32-,33+,34-,35-,36-,39-,40-/m0/s1
Standard InChI Key: OKSWHNWFJYITBL-BEZWDVRRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1238.97 | Molecular Weight (Monoisotopic): 1238.3383 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hsieh K, Kiraly-Olah IC, Jorgensen EC, Lee TC.. (1979) Angiotensin II analogues. 13. Role of the hydroxyl group of position 4 tyrosine in pressor activity., 22 (9): [PMID:490549] [10.1021/jm00195a008] |
Source(1):